Literature DB >> 29388032

The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study.

Ming Chen1, Shi-Hao Zheng2, Min Yang1, Zhi-Hua Chen3, Shi-Ting Li4.   

Abstract

To compare the different levels of preoperative inflammatory markers in peripheral blood samples between craniopharyngioma (CP) and other sellar region tumors so as to explore their differential diagnostic value. The level of white blood cell (WBC), neutrophil, lymphocyte, monocyte, platelet, albumin, neutrophil lymphocyte ratio (NLR), derived NLR (dNLR), platelet lymphocyte ratio (PLR), monocyte lymphocyte ratio (MLR) and prognostic nutritional index (PNI) were compared between the CP and other sellar region tumors. A receiver operating characteristics (ROC) curve analysis was performed to evaluate the diagnostic significance of the peripheral blood inflammatory markers and their paired combinations for CP including its pathological types. Patients with CP had higher levels of pre-operative WBC, lymphocyte and PNI. The papillary craniopharyngioma (PCP) group had higher neutrophil count and NLR than the adamantinomatous craniopharyngioma (ACP) and healthy control groups whereas the ACP group had higher platelet count and PNI than the PCP and healthy control groups. There were not any significant differences in preoperative inflammatory markers between the primary and recurrent CP groups. The AUC values of WBC, neutrophil, NLR + PLR and dNLR + PLR in PCP were all higher than 0.7. Inflammation seems to be closely correlated with CP's development. The preoperative inflammatory markers including WBC, neutrophil, NLR + PLR and dNLR + PLR may differentially diagnose PCP, pituitary tumor (PT) and Rathke cleft cyst (RCC). In addition, some statistical results in this study indirectly proved previous experimental conclusions and strictly matched CP's biological features.

Entities:  

Keywords:  Craniopharyngioma; Differential diagnosis; Inflammation; Peripheral blood; Recurrence

Mesh:

Substances:

Year:  2018        PMID: 29388032     DOI: 10.1007/s11060-018-2776-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  39 in total

Review 1.  The pathogenesis of craniopharyngiomas.

Authors:  Vikram C Prabhu; Henry G Brown
Journal:  Childs Nerv Syst       Date:  2005-06-18       Impact factor: 1.475

Review 2.  Circulating glioma biomarkers.

Authors:  Johan M Kros; Dana M Mustafa; Lennard J M Dekker; Peter A E Sillevis Smitt; Theo M Luider; Ping-Pin Zheng
Journal:  Neuro Oncol       Date:  2014-09-24       Impact factor: 12.300

3.  Periostin activates pathways involved in epithelial-mesenchymal transition in adamantinomatous craniopharyngioma.

Authors:  Ming Chen; Shi-hao Zheng; Yi Liu; Jin Shi; Song-tao Qi
Journal:  J Neurol Sci       Date:  2015-11-23       Impact factor: 3.181

4.  Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis.

Authors:  Seema Singh; Anguraj Sadanandam; Kalyan C Nannuru; Michelle L Varney; Rosemary Mayer-Ezell; Richard Bond; Rakesh K Singh
Journal:  Clin Cancer Res       Date:  2009-03-17       Impact factor: 12.531

5.  Expression of interleukin-6 in human craniopharyngiomas: a possible inducer of tumor-associated inflammation.

Authors:  Masanao Mori; Hideo Takeshima; Jun-ichi Kuratsu
Journal:  Int J Mol Med       Date:  2004-10       Impact factor: 4.101

6.  Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as potential biomarkers for early detection and monitoring of colorectal adenocarcinoma.

Authors:  Serta Kilincalp; Şahin Çoban; Hakan Akinci; Mevlüt Hamamcı; Fatih Karaahmet; Yusuf Coşkun; Yusuf Üstün; Zahide Şimşek; Elife Erarslan; İlhami Yüksel
Journal:  Eur J Cancer Prev       Date:  2015-07       Impact factor: 2.497

7.  Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma.

Authors:  Cynthia L Andoniadou; Carles Gaston-Massuet; Rukmini Reddy; Ralph P Schneider; Maria A Blasco; Paul Le Tissier; Thomas S Jacques; Larysa H Pevny; Mehul T Dattani; Juan Pedro Martinez-Barbera
Journal:  Acta Neuropathol       Date:  2012-02-18       Impact factor: 17.088

8.  Identification of targets for rational pharmacological therapy in childhood craniopharyngioma.

Authors:  Jacob M Gump; Andrew M Donson; Diane K Birks; Vladimir M Amani; Karun K Rao; Andrea M Griesinger; B K Kleinschmidt-DeMasters; James M Johnston; Richard C E Anderson; Amy Rosenfeld; Michael Handler; Lia Gore; Nicholas Foreman; Todd C Hankinson
Journal:  Acta Neuropathol Commun       Date:  2015-05-21       Impact factor: 7.801

9.  Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth.

Authors:  Wenchao Zhou; Susan Q Ke; Zhi Huang; William Flavahan; Xiaoguang Fang; Jeremy Paul; Ling Wu; Andrew E Sloan; Roger E McLendon; Xiaoxia Li; Jeremy N Rich; Shideng Bao
Journal:  Nat Cell Biol       Date:  2015-01-12       Impact factor: 28.824

Review 10.  Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity.

Authors:  Hermann L Müller
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-02       Impact factor: 3.243

View more
  7 in total

1.  A comprehensive model including preoperative peripheral blood inflammatory markers for prediction of the prognosis of diffuse spinal cord astrocytoma following surgery.

Authors:  Bo Pang; Rui-Chao Chai; Yao-Wu Zhang; Yu-Zhou Chang; Wei-Hao Liu; Wen-Qing Jia; Yong-Zhi Wang
Journal:  Eur Spine J       Date:  2021-01-25       Impact factor: 3.134

2.  Prediction of calcification tendency in pediatric cystic adamantinomatous craniopharyngioma by using inflammatory markers, hormone markers, and radiological appearances.

Authors:  Ming Chen; Zhang Zhang; Min Yang; Shi-Ting Li
Journal:  Childs Nerv Syst       Date:  2019-05-07       Impact factor: 1.475

3.  Correlation between preoperative inflammatory markers, Ki-67 and the pathological grade of glioma.

Authors:  Guangda Xu; Chengxue Li; Yanguo Wang; Jinan Ma; Junchen Zhang
Journal:  Medicine (Baltimore)       Date:  2021-09-10       Impact factor: 1.817

4.  Pre-operative serum inflammation-based scores in patients with pituitary adenomas.

Authors:  Pedro Marques; Friso de Vries; Olaf M Dekkers; Wouter R van Furth; Márta Korbonits; Nienke R Biermasz; Alberto M Pereira
Journal:  Pituitary       Date:  2020-11-24       Impact factor: 4.107

5.  Spinal Obstruction-Related vs. Craniocervical Junction-Related Syringomyelia: A Comparative Study.

Authors:  Chenghua Yuan; Jian Guan; Yueqi Du; Zeyu Fang; Xinyu Wang; Qingyu Yao; Can Zhang; Shanhang Jia; Zhenlei Liu; Kai Wang; Wanru Duan; Xingwen Wang; Zuowei Wang; Hao Wu; Zan Chen; Fengzeng Jian
Journal:  Front Neurol       Date:  2022-08-01       Impact factor: 4.086

Review 6.  Serum Inflammation-based Scores in Endocrine Tumors.

Authors:  Pedro Marques; Friso de Vries; Olaf M Dekkers; Márta Korbonits; Nienke R Biermasz; Alberto M Pereira
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 5.958

7.  Development of a Nomogram Based on Preoperative Bi-Parametric MRI and Blood Indices for the Differentiation Between Cystic-Solid Pituitary Adenoma and Craniopharyngioma.

Authors:  Zhen Zhao; Dongdong Xiao; Chuansheng Nie; Hao Zhang; Xiaobing Jiang; Ali Rajab Jecha; Pengfei Yan; Hongyang Zhao
Journal:  Front Oncol       Date:  2021-07-09       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.